Royce & Associates LP Boosts Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

Royce & Associates LP grew its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 12.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 510,261 shares of the company’s stock after buying an additional 55,545 shares during the quarter. Royce & Associates LP owned 0.40% of Surgery Partners worth $16,451,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. KBC Group NV grew its holdings in shares of Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company’s stock valued at $77,000 after buying an additional 576 shares during the last quarter. DekaBank Deutsche Girozentrale grew its holdings in shares of Surgery Partners by 102.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after buying an additional 1,375 shares during the last quarter. Quarry LP grew its holdings in shares of Surgery Partners by 133.1% during the second quarter. Quarry LP now owns 3,082 shares of the company’s stock valued at $73,000 after buying an additional 1,760 shares during the last quarter. EntryPoint Capital LLC grew its holdings in shares of Surgery Partners by 257.1% during the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock valued at $191,000 after buying an additional 4,607 shares during the last quarter. Finally, Creative Planning purchased a new stake in shares of Surgery Partners during the third quarter valued at approximately $258,000.

Surgery Partners Stock Down 7.3 %

SGRY opened at $22.95 on Friday. The company has a current ratio of 1.80, a quick ratio of 1.69 and a debt-to-equity ratio of 0.99. Surgery Partners, Inc. has a 1-year low of $22.25 and a 1-year high of $36.92. The company has a market capitalization of $2.92 billion, a PE ratio of -47.81, a PEG ratio of 18.74 and a beta of 2.76. The firm’s 50 day simple moving average is $30.62 and its two-hundred day simple moving average is $28.43.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Macquarie lowered their price objective on shares of Surgery Partners from $35.00 to $34.00 and set an “outperform” rating on the stock in a research report on Wednesday. Cantor Fitzgerald restated an “overweight” rating and set a $43.00 price objective on shares of Surgery Partners in a research report on Friday, October 4th. Benchmark restated a “buy” rating and set a $50.00 price objective on shares of Surgery Partners in a research report on Monday, August 26th. StockNews.com downgraded shares of Surgery Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, August 7th. Finally, KeyCorp assumed coverage on shares of Surgery Partners in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. One analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, Surgery Partners presently has an average rating of “Moderate Buy” and an average target price of $40.71.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.